CN101229266A - Medicine for curing psoriasis - Google Patents
Medicine for curing psoriasis Download PDFInfo
- Publication number
- CN101229266A CN101229266A CNA2008100085860A CN200810008586A CN101229266A CN 101229266 A CN101229266 A CN 101229266A CN A2008100085860 A CNA2008100085860 A CN A2008100085860A CN 200810008586 A CN200810008586 A CN 200810008586A CN 101229266 A CN101229266 A CN 101229266A
- Authority
- CN
- China
- Prior art keywords
- parts
- portions
- radix
- medicine
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a safe and effective medicine for psoriasis treatment, which is formed by the raw materials with the following weight account, garter snake 10 to 20 portions, catnip of 5 to 10 portions, windbreaking of 5 to 10 portions, cicada skin of 5 to 10 part, fructuskochiae of 5 to 10 portions, osthol of 5 to 10 portions, dittany skin of 5 to 10 portions, charles abraham of 5 to 10 portions, lightyellow sophora root of 5 to 10 portions, phellodendron of 5 to 10 portions, and astragalus of 7.5 to 15 portions. The preparation method of the invention is: grounding the raw materials into fine powder, mixing evenly, and putting into the capsule. Meanwhile, the traditional Chinese medicine has no obvious side effect.
Description
Technical field
The present invention relates to the psoriatic Chinese patent medicine of a kind of treatment.
Background technology
Psoriasis is commonly called as " psoriasis ", be that to be coated with silvery white squama companion pruritus with erythema be a kind of chronic hyperproliferative skin disease of main clinical manifestation, commonly encountered diseases comparatively, for seeing, this disease does not still have special efficacy at present more with person between twenty and fifty, and Western medicine is with immunosuppressant, treatments such as hormone, but only can relief of symptoms, can not cure fully, side effect is more.
Summary of the invention
The object of the invention provides a kind of psoriatic medicine for the treatment of safely and effectively.
The present invention is made by following materials of weight proportions medicine,
Zaocys 10-20 part, Herba Schizonepetae 5-10 part, Radix Saposhnikoviae 5-10 part, Periostracum Cicadae 5-10 part, Fructus Kochiae 5-10 part,
Fructus Cnidii 5-10 part, favus skin 5-10 part, Radix Rehmanniae 5-10 part, Radix Sophorae Flavescentis 5-10 part, Cortex Phellodendri 5-10 part
With Radix Astragali 7.5-15 part.
In preferred version, the present invention is made by following materials of weight proportions medicine,
20 parts of Zaocys, 10 parts of Herba Schizonepetae, 10 parts of Radix Saposhnikoviaes, 10 parts of Periostracum Cicadaes, 10 parts of the Fructus Kochiae,
10 parts of Fructus Cnidiis, 10 parts of favus skins, 10 parts in the Radix Rehmanniae, 10 parts of Radix Sophorae Flavescentiss, 10 parts of Cortex Phellodendris and
15 parts of the Radixs Astragali.
The dosage form that crude drug of the present invention is made is a capsule, and the fineness of pulverulent mixture is greater than 80 orders in the capsule.
Preparation method of the present invention is that above-mentioned each crude drug is ground into fine powder, and uniform mixing incapsulates and gets final product.
Instructions of taking is to obey 2-3 time every day, obeys 3.0g-5.0g at every turn.
Psoriasis be the ailment said due to cold or exposure visitor in skin, coagulation of QI-blood is the cause of primary disease, thus this medicament take to dispel the wind, heat clearing and damp drying for the treatment rule.With the Zaocys expelling wind and dampness, be monarch drug in the side; Herba Schizonepetae, Radix Saposhnikoviae, Periostracum Cicadae expelling pathogenic wind from the body surface, the Fructus Kochiae, Fructus Cnidii, the favus skin detoxifying and relieving itching of dispeling the wind is ministerial drug.Heat in blood often causes damp and hotly accumulates long-pendingly, and big poison is flourishing, and Fang Zhongzuo is a clearing away heat and cooling blood with the Radix Rehmanniae, Radix Sophorae Flavescentis, Cortex Phellodendri, eliminating fire and detoxication.Make it Radix Astragali consolidating superficial resistance QI invigorating, strengthening body resistance and dispelling evil is built up resistance, and repairs the skin lesion effect, with treating both the principal and secondary aspects of a disease.
Chinese herbal medicine of the present invention, non-evident effect.
Clinical trial of the present invention is as follows:
1, physical data: male 20 examples in 28 examples, women 8 examples;
Age 6-12 year person's 9 examples, 20-40 year 17 examples, 40-50 year 2 examples.
2, diagnostic criteria:
Heat in blood disease: as seen differ in size maculopapule, patch, color of trunk or whole skin is scarlet, is covered with silvery white squama, and point-like blood point is arranged after striking off, and with pruritus, does not have obviously heating.
Syndrome of blood stasis: the general course of disease is longer, and skin lesion is speckle ramp of a bridge shape, and is hard slightly, and color is dark red to be covered with silvery white squama and to occur together and itch etc.
3, Therapeutic Method:
Oral medicine of the present invention is powder or incapsulates the 0.3g/ grain, every day 2-3 time, each 3.0-5.0g (being the 10-16 grain).Serveing on for 2 weeks is a course of treatment, and the longest 6 weeks cure.
4, curative effect judging standard:
(1) clinical recovery: skin lesion all disappears.
(2) produce effects: skin lesion disappears more than 70%.
(3) effective: skin lesion disappears more than 30%.
(4) invalid: skin lesion disappears below 30%, or the skin lesion no change, or skin lesion increases the weight of.
5, observation of curative effect:
Observe in 28 examples 20 examples of fully recovering, effective 8 examples, total effective rate 100%.
(1) relapse rate: clinical cure 28 examples, example recurrence in 6 months subsequently 2, relapse rate accounts for 7%, takes this medicine once more and still produces effect.
(2) untoward reaction: take during this medicine, have the minority case xerostomia, poor appetite to occur, be hard and dry.In 28 example treatments after have a blood test, routine urinalysis and liver function there is no ANOMALOUS VARIATIONS.
Model case:
The patient opens * *, man, 29 years old, stone bridge town, Li County, * * people from village, because of whole body squama sample maculopapule was accompanied pruritus 1 year, go to a doctor on April 8th, 2006, the patient is in going the year before Beijing (building worker) no obvious cause of doing manual work silver to occur the body cadre and consider maculopapule to be worth doing, reaches extremity gradually and occurs together and itch, sought medical advice in certain hospital once, give treatment such as oral western medicine and pin medication (medication is not quite clear) with the quiet disease of silver, poor effect, the time heavy when light, the state of an illness increases the weight of to some extent the bimester of near, returns the local and goes to a doctor.Body is looked into: T36.8 ℃, P78 time/minute, R20 time/minute, development nutrition is medium, and spirit is good, the visible silvery white squama maculopapule of trunk and extremity, and tenderness is not obvious, not enlargement of superficial lymph node, cardiopulmonary (-), the liver spleen does not touch, and dorsal column does not have deformity.Have a blood test, routine urinalysis, hepatic and renal function, Chest X-rays are no abnormal.Give this medicine each 5.0g, three times on the one, serve on for two weeks, skin lesion disappears gradually, pruritus alleviates, serve on for 4 weeks after, skin lesion disappears fully, with not seeing recurrence later six months.
The specific embodiment
The following examples can make those skilled in the art more fully understand the present invention, but do not limit the present invention in any way.
Embodiment 1: prescription:
Zaocys 200g Herba Schizonepetae 100g Radix Saposhnikoviae 100g Periostracum Cicadae 100g
Fructus Kochiae 100g Fructus Cnidii 100g favus skin 100g Radix Rehmanniae 100g
Radix Sophorae Flavescentis 100g Cortex Phellodendri 100g Radix Astragali 150g
Preparation method: with above-mentioned raw materials medicine Zaocys, Herba Schizonepetae, Radix Saposhnikoviae, Periostracum Cicadae, the Fructus Kochiae, Fructus Cnidii, favus skin, the Radix Rehmanniae, Radix Sophorae Flavescentis, Cortex Phellodendri, the Radix Astragali by above-mentioned weight proportion mixed grinding fine powder, stir, incapsulate, every capsules is gone into medicated powder 0.3g.
Embodiment 2: prescription:
Zaocys 100g Herba Schizonepetae 50g Radix Saposhnikoviae 50g Periostracum Cicadae 50g
Fructus Kochiae 50g Fructus Cnidii 50g favus skin 50g Radix Rehmanniae 50g
Radix Sophorae Flavescentis 50g Cortex Phellodendri 50g Radix Astragali 75g
Preparation method: with above-mentioned raw materials medicine Zaocys, Herba Schizonepetae, Radix Saposhnikoviae, Periostracum Cicadae, the Fructus Kochiae, Fructus Cnidii, favus skin, the Radix Rehmanniae, Radix Sophorae Flavescentis, Cortex Phellodendri, the Radix Astragali by above-mentioned weight proportion mixed grinding fine powder, stir, incapsulate, every capsules is gone into medicated powder 0.3g.
Embodiment 3: prescription:
Zaocys 150g Herba Schizonepetae 75g Radix Saposhnikoviae 75g Periostracum Cicadae 75g
Fructus Kochiae 75g Fructus Cnidii 75g favus skin 75g Radix Rehmanniae 75g
Radix Sophorae Flavescentis 75g Cortex Phellodendri 75g Radix Astragali 112g
Preparation method: with above-mentioned raw materials medicine Zaocys, Herba Schizonepetae, Radix Saposhnikoviae, Periostracum Cicadae, the Fructus Kochiae, Fructus Cnidii, favus skin, the Radix Rehmanniae, Radix Sophorae Flavescentis, Cortex Phellodendri, the Radix Astragali by above-mentioned weight proportion mixed grinding fine powder, stir, incapsulate, every capsules is gone into medicated powder 0.3g.
Claims (3)
1. treat psoriatic medicine for one kind, it is characterized in that: it is to be made by following materials of weight proportions medicine,
Zaocys 10-20 part, Herba Schizonepetae 5-10 part, Radix Saposhnikoviae 5-10 part, Periostracum Cicadae 5-10 part, Fructus Kochiae 5-10 part,
Fructus Cnidii 5-10 part, favus skin 5-10 part, Radix Rehmanniae 5-10 part, Radix Sophorae Flavescentis 5-10 part, Cortex Phellodendri 5-10 part and
Radix Astragali 7.5-15 part.
2. the psoriatic medicine of treatment according to claim 1 is characterized in that: it is to be made by following materials of weight proportions medicine,
20 parts of Zaocys, 10 parts of Herba Schizonepetae, 10 parts of Radix Saposhnikoviaes, 10 parts of Periostracum Cicadaes, 10 parts of the Fructus Kochiae,
10 parts of Fructus Cnidiis, 10 parts of favus skins, 10 parts in the Radix Rehmanniae, 10 parts of Radix Sophorae Flavescentiss, 10 parts of Cortex Phellodendris and
15 parts of the Radixs Astragali.
3. the psoriatic medicine of treatment according to claim 1 and 2 is characterized in that: the dosage form that crude drug is made is a capsule, and the fineness of pulverulent mixture is greater than 80 orders in the capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100085860A CN101229266B (en) | 2008-01-25 | 2008-01-25 | Medicine for curing psoriasis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100085860A CN101229266B (en) | 2008-01-25 | 2008-01-25 | Medicine for curing psoriasis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101229266A true CN101229266A (en) | 2008-07-30 |
CN101229266B CN101229266B (en) | 2010-10-13 |
Family
ID=39896280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100085860A Expired - Fee Related CN101229266B (en) | 2008-01-25 | 2008-01-25 | Medicine for curing psoriasis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101229266B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103055200A (en) * | 2013-01-17 | 2013-04-24 | 孟桂梅 | Chinese medicinal herb composition for treating wind-heat type psoriasis and preparation method thereof |
CN103405718A (en) * | 2013-08-08 | 2013-11-27 | 李盛民 | TCM pill for treating psoriasis |
CN104689139A (en) * | 2015-04-04 | 2015-06-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating psoriasis vulgaris |
CN106237203A (en) * | 2016-10-21 | 2016-12-21 | 吉林省圣奥生物科技有限公司 | Treat psoriatic ointment |
CN106729221A (en) * | 2017-03-31 | 2017-05-31 | 天津迈拓思生物科技有限公司 | A kind of Chinese medicine composition for treating psoriasis |
CN107334857A (en) * | 2017-07-07 | 2017-11-10 | 王浩绪 | One kind treats psoriasic medicine for oral administration |
CN108704026A (en) * | 2018-07-28 | 2018-10-26 | 余胜福 | A kind of Chinese medicine treats the external application prescription for disease disease of itching |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1377659A (en) * | 2001-04-03 | 2002-11-06 | 王传江 | Rash-eliminating and psoriasis-treating medicine liquid |
CN100409870C (en) * | 2005-04-05 | 2008-08-13 | 赵修宝 | Chinese traditional medicinal composition for treating psoriasis |
CN1772100A (en) * | 2005-10-26 | 2006-05-17 | 邢继华 | Medicine for treating psoriasis and its prepn |
-
2008
- 2008-01-25 CN CN2008100085860A patent/CN101229266B/en not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103055200A (en) * | 2013-01-17 | 2013-04-24 | 孟桂梅 | Chinese medicinal herb composition for treating wind-heat type psoriasis and preparation method thereof |
CN103405718A (en) * | 2013-08-08 | 2013-11-27 | 李盛民 | TCM pill for treating psoriasis |
CN104689139A (en) * | 2015-04-04 | 2015-06-10 | 淄博夸克医药技术有限公司 | Traditional Chinese medicine for treating psoriasis vulgaris |
CN106237203A (en) * | 2016-10-21 | 2016-12-21 | 吉林省圣奥生物科技有限公司 | Treat psoriatic ointment |
CN106729221A (en) * | 2017-03-31 | 2017-05-31 | 天津迈拓思生物科技有限公司 | A kind of Chinese medicine composition for treating psoriasis |
CN107334857A (en) * | 2017-07-07 | 2017-11-10 | 王浩绪 | One kind treats psoriasic medicine for oral administration |
CN108704026A (en) * | 2018-07-28 | 2018-10-26 | 余胜福 | A kind of Chinese medicine treats the external application prescription for disease disease of itching |
Also Published As
Publication number | Publication date |
---|---|
CN101229266B (en) | 2010-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100450526C (en) | Chinese medicinal formulation for treating rheumatic and rheumatoid disease | |
CN101229266B (en) | Medicine for curing psoriasis | |
CN102008655B (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method thereof | |
CN1868535A (en) | Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method | |
CN103142903B (en) | Traditional Chinese medicine preparation for treating psoriasis | |
CN103055260A (en) | Traditional Chinese medicine composition for treating ulcerative colitis and preparation method thereof | |
CN101181438A (en) | Chinese medicine preparation for curing extremity tinea | |
CN103446575B (en) | Medicine for treating gout | |
CN102988886A (en) | Chinese medicament for treating obesity | |
CN105012833A (en) | Traditional Chinese medicine for treating polyneuropathy | |
CN102657839B (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
CN104173853A (en) | Drug for treating ocular myasthenia gravis | |
CN102813867A (en) | Traditional Chinese medicinal plaster treating rheumatic arthritis | |
CN105816825A (en) | Orthopaedics department black plaster and preparation method thereof | |
CN101780216A (en) | Medicine for treating psoriasis | |
CN101879295B (en) | Traditional Chinese medicine decoction for treating blood stasis type psoriasis | |
CN102058842B (en) | Traditional Chinese medicine composition for treating hemiplegic stroke or premonitory apoplexy | |
CN101168011A (en) | Traditional Chinese medicine capsule for treating gastritis, stomach and duodenum ulcer and preparation method | |
CN101036742B (en) | Medicine for treating prostatic disease | |
CN102940837A (en) | Chinese medicinal composition for treating migraine | |
CN106668787A (en) | Traditional Chinese medicine honeyed pill for treating hepatonecrosis and liver cancer and preparation method of traditional Chinese medicine honeyed pill | |
CN103099889B (en) | Traditional Chinese medicine wine for treating lumbar spinal stenosis | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN1089160A (en) | " Biantianfengshiqing " medicine for treating rheumatism | |
CN107158322A (en) | It is a kind of to be used for gout, soft tissue injury, preparation of rheumatalgia pain and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101013 Termination date: 20130125 |
|
CF01 | Termination of patent right due to non-payment of annual fee |